SPOP and prostate neoplasm: More importantly SPOP mutations/CHD1 deletions define a molecular subgroup of prostate tumours which is characterised by moderate to high copy number aberration, elevated levels of DNA methylation (methylation cluster 2), homogeneous gene expression profile (mRNA cluster 1) and is mutually exclusive with ETS transcription factor gene fusions.